-
Uncategorized5 days ago
Aspect Biosystems gets $79M from Canadian government for diabetes cell therapy
An ambitious Vancouver startup is trying to ensure the next big diabetes breakthrough retains its ties to Canada, unlike the insulin developers of a century ago....
-
Uncategorized5 days ago
Blocking AhR Sensor Activates Regenerative Program in Injured Neurons
A molecular switch in neurons regulates the regrowth of damaged axonal fibers. This is according to findings in mice, published in a new Nature paper titled...
-
Uncategorized5 days agoSTAT+: FDA’s evolving view of what makes a ‘breakthrough’ device
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your...
-
Uncategorized5 days ago
DOJ weighs in favor of pharma on 340B dispute
Pharma is gaining ground in a yearslong struggle over access to federal drug discounts. Drugmakers and the federal government have historically been on opposing sides of...
-
Uncategorized5 days agoImmunovant eye drug flunks Phase 3 studies; Beam sickle cell data published in NEJM
Shares of Immunovant, Alto and Oric Pharmaceuticals fell this week on clinical trial updates. Elsewhere, Orca Bio’s cell therapy hit a delay and Korsana entered a...
-
Uncategorized5 days ago
Novo and Lilly battle over GLP-1 claims only a head-to-head trial can answer
A day after Eli Lilly gained FDA approval for its obesity pill Foundayo, Novo Nordisk is fighting back with an analysis that it says shows the...
-
Uncategorized5 days ago
UK signs off on US pharma deal, ensuring tariff reprieve as Britain aims to reattract investments
The U.K.’s end of the deal requires it to spend more on drugs through its National Health Service, which it is implementing through a higher cost-effectiveness...
-
Uncategorized5 days ago
Drug substance maker raises prices due to energy crisis; SpectronRX gets $85M
Plus, news about Scinai Immunotherapeutics and Cardinal Health: 📈 Drug ingredients company raises prices: As the war in the Middle East continues, BASF Pharma Solutions said...
-
Uncategorized5 days ago
Trump is preparing 100% tariffs on some drugmakers, documents show
President Donald Trump is reportedly set to implement 100% pharmaceutical tariffs as soon as Thursday, but according to a draft seen by Endpoints News, it appears...
-
Uncategorized5 days agoSTAT+: Lilly’s obesity pill enters the oral GLP-1 game, Novo responds
The FDA yesterday approved Eli Lilly’s weight loss pill, orforglipron. The agency is also facing renewed scrutiny over transparency gaps related to advisory committee conflicts, and its...
A star scientist showed that better genetics lessons could reduce racism. It was the death knell for his career
Opinion: STAT+: Former Geisinger CEO: U.S. health systems must replace huge numbers of people with AI
